LUCIANA THOMPSON: Open Payments
NPI 1952860744 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 19 payments from 7 companies in 2025. Trend: 2023 $3,044 · 2024 $3,152 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $99 |
| Janssen Pharmaceuticals, Inc | 4 | $70 |
| Alkermes, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, ARISTADA, VRAYLAR, INGREZZA, REXULTI, COBENFY, UZEDY.
Industry payments across TX — which companies pay providers there.
